arrow
K

Kenneth Kalunian

laval university hospital
H指数:73
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring

定义羟氯喹在狼疮中最佳安全有效的血药浓度:迈向精准药物监测的重要一步

2026-02-013
OAAI
2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus

2025年美国风湿病学会(ACR)系统性红斑狼疮治疗指南

2025-11-040
PRE
2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus

2025年美国风湿病学会(ACR)系统性红斑狼疮治疗指南

2025-11-030
PRE
Patient outcomes from implementing a shared decision-making aid for systemic lupus erythematosus: a prospective implementation study

系统性红斑狼疮患者实施共享决策辅助工具后的结局:一项前瞻性实施研究

2025-09-170
PRE
A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis

人类-小鼠肾脏内髓系细胞图谱鉴定了狼疮肾炎中保守的疾病相关巨噬细胞

2025-09-031
PRE
2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis

2024年美国风湿病学会(ACR)关于狼疮肾炎筛查、治疗和管理的指南

2025-05-070
PRE
Long-term effect of anifrolumab on patient-reported outcomes in systemic lupus erythematosus (TULIP-LTE): a randomised, placebo-controlled, phase 3 long-term extension trial

阿尼夫罗鲁单抗对系统性红斑狼疮患者报告结局的长期影响(TULIP-LTE):一项随机、安慰剂对照、III期长期扩展试验

2025-05-020
PRE
LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trialsI

LLDAS与安尼福卢单抗治疗系统性红斑狼疮患者中缓解的达成:来自TULIP和长期扩展随机对照试验的结果

2025-01-010
PRE
VOCLOSPORIN-BASED, TRIPLE-IMMUNOSUPPRESSIVE REGIMEN VERSUS HIGH-DOSE GLUCOCORTICOID AND MYCOPHENOLATE MOFETIL-BASED THERAPY FOR LUPUS NEPHRITIS: A PROPENSITY ANALYSIS OF THE ALMS, AURA-LV AND AURORA 1 STUDIES

基于Voclosporin的三联免疫抑制方案与高剂量糖皮质激素和Mycophenolate Mofetil为基础的疗法治疗狼疮肾炎:ALMS、AURA-LV和AURORA 1研究的倾向性分析

2024-06-010
PRE
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus

系统性红斑狼疮的Anti-KIF20B自身抗体与颅神经病变相关

2024-04-090
OAAI
Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial

系统性红斑狼疮患者停用霉酚酸酯: 一项多中心、开放标签、随机对照试验

2024-03-015
PRE
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis
2024-01-2312
OAAI